FDA commissioner resigns, widening leadership void at U.S. Health Department
Dr. Marty Makary stepped down as the commissioner of the Food and Drug Administration, leaving the agency with only an acting head. His resignation adds to a series of vacant senior posts at the U.S. Department of Health and Human Services, including an unfilled surgeon‑general seat, an acting head of the CDC, and a dual‑role acting head of the NIH and CDC.
The departures come amid criticism that the department lacks scientific expertise and faces policy clashes between Health Secretary Robert F. Kennedy Jr.’s anti‑corporate agenda and traditional Republican opposition to regulation. Makary’s exit leaves unfinished initiatives on ultra‑processed foods, food dyes, antidepressants and COVID‑19 vaccines, tasks now shouldered by acting deputy commissioner Kyle Diamantas, a non‑scientist appointed by former President Trump.
Observers warn that the leadership gap could undermine the agencies’ ability to respond effectively to public health emergencies and erode public trust in federal health institutions.